FDA Issues Import Alert for New Tobacco Products

May.18.2023
FDA Issues Import Alert for New Tobacco Products
The FDA issues Import Alert 98-06 to detain unapproved new tobacco products from various countries and brands.

On May 17th, the US Food and Drug Administration (FDA) issued an "import alert" (Import Alert 98-06) stating that the FDA will detain "new tobacco products not approved for market entry and not subject to inspection." The alert targets importers, manufacturers, and transporters of electronic cigarette brands such as ELFBAR, EBDESIGN, Esco Bar, and others from China, South Korea, and the US.


Warning Regulations | Photo source: FDA


It is reported that an import alert is used to prevent potentially non-compliant products from being sold in the United States, free up agency resources to inspect other goods, provide uniform coverage nationwide, and shift responsibility back to the importer to ensure that products imported into the US comply with FDA laws and regulations.


In June 2009, the Family Smoking Prevention and Tobacco Control Act granted the FDA the authority to regulate tobacco products, recognizing it as the primary federal regulatory agency for the manufacture, marketing, and distribution of cigarettes, cigarette tobacco, and smokeless tobacco. The finalized regulations were published in the Federal Register on May 10, 2016 and went into effect on August 8, 2016, expanding the FDA's oversight to include designated tobacco products such as e-cigarettes, cigars, hookah tobacco, and pipe tobacco along with their components and parts, but not accessories.


Products that meet the definition of "new tobacco products" must comply with the pre-market requirements outlined in sections 910 and 905 of the Federal Food, Drug, and Cosmetic Act. According to section 902(6)(A) of the Federal Food, Drug, and Cosmetic Act, new tobacco products that have not received the necessary marketing authorization from the FDA are considered adulterated, while failure to comply with the notification and other information requirements outlined in section 905(j) of the Federal Food, Drug, and Cosmetic Act results in misbranding under 21 U.S.C. 387e(j).


The FDA has issued a marketing denial order to 10 companies, affecting 6,500 flavored electronic cigarettes and vaping liquid products. The companies receiving the order are prohibited from selling or distributing these products in the US market. Retailers continuing to sell these illegal products will face enforcement action from the FDA.


Heaven Gifts International Limited's images are sourced from the FDA.


IMiracle Shenzhen Technology Co. Ltd., image sourced from FDA.


First Union | Image Source: FDA


Innokin | Photo credit: FDA


More coverage on 2FIRSTS will be provided in the future. Please stay tuned.


Reference:


The Import Alert 98-06 has been issued.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
A study using 2020–2023 U.S. data from the ITC Youth Tobacco and Vaping Survey (ages 16–19) reports that both nicotine/tobacco use and internalizing mental health (IMH) symptoms vary across disaggregated gender identities, and that gender identity moderates the relationship between IMH symptoms and product use.
Feb.27 by 2FIRSTS.ai
Poland Weighs Ban on Disposable Vapes, Tightens Rules on Nicotine Pouches
Poland Weighs Ban on Disposable Vapes, Tightens Rules on Nicotine Pouches
Poland plans to amend its tobacco control legislation, proposing a ban on disposable e-cigarettes (both nicotine-containing and nicotine-free) while simultaneously tightening regulations on nicotine pouches and other novel nicotine products. Nicotine pouches may be permitted only in "tobacco flavour" variants to reduce their appeal to young people.
Mar.10 by 2FIRSTS.ai
Product | GEEKBAR Expands High-Puff Lineup; CLR 50K and Clio X Highlight Displays and Transparent E-Liquid Tanks
Product | GEEKBAR Expands High-Puff Lineup; CLR 50K and Clio X Highlight Displays and Transparent E-Liquid Tanks
GEEKBAR has added two new vaping products on its official website. Both feature transparent e-liquid tanks and are rated for up to 50,000 puffs. The CLR 50K is equipped with a 17 ml e-liquid capacity, is labeled at 5% nicotine (50 mg/ml), and offers Normal and Pulse modes, while the Clio X carries a 16 ml capacity, a dual-screen display, and three output modes.
Feb.28 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows
Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows
Spain’s 2025 Survey on Drug Use in Secondary Education (ESTUDES), presented by the Ministry of Health, reports historic lows in alcohol, tobacco and cannabis consumption among students aged 14 to 18. The survey shows past-30-day drinking fell from 56.6% in 2023 to 51% in 2025, tobacco use from 21.0% to 15.5%, and cannabis use from 15.5% to 11.6%.
Feb.09 by 2FIRSTS.ai